Mainz Biomed B.V.
NASDAQ:MYNZ
0.2541 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -26.296 | -26.387 | -11.69 | -0.587 | -0.957 |
| Depreciation & Amortization
| 0.866 | 0.38 | 0.07 | 0.06 | 0.053 |
| Deferred Income Tax
| 0.042 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 4.006 | 9.824 | 6.43 | 0 | 0 |
| Change In Working Capital
| -0.065 | 1.387 | -0.139 | 0.058 | 0.423 |
| Accounts Receivables
| 0.016 | -0.211 | 0.024 | -0.099 | 0.34 |
| Inventory
| -0.5 | -0.172 | -670.725 | -0.16 | 0 |
| Accounts Payables
| 0.72 | 1,824.402 | 670.725 | 0.16 | 0 |
| Other Working Capital
| -0.3 | -1,822.631 | -0.163 | 0.157 | 0.083 |
| Other Non Cash Items
| -0.493 | 0.027 | 2.108 | 0 | 0.064 |
| Operating Cash Flow
| -21.939 | -14.77 | -3.22 | -0.469 | -0.416 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -1.899 | -0.658 | -0.017 | -0.01 | 0 |
| Acquisitions Net
| 0 | 0 | 1.22 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.7 | 0 | 1.22 | 0 | 0 |
| Investing Cash Flow
| -1.899 | -0.658 | 1.203 | -0.01 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| -2.286 | -0.305 | -0.061 | -0.039 | -0.03 |
| Common Stock Issued
| 6.393 | 23.866 | 10.425 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.934 | 0.383 | 0.247 | 0.436 | 0.454 |
| Financing Cash Flow
| 14.227 | 23.943 | 10.611 | 0.397 | 0.424 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.46 | -0.101 | 0.012 | 0.001 | -0.033 |
| Net Change In Cash
| -10.071 | 8.414 | 8.605 | -0.081 | -0.026 |
| Cash At End Of Period
| 7.071 | 17.142 | 8.728 | 0.123 | 0.204 |